Merck Animal Health Completes Acquisition of Quantified Ag®
June 17 2020 - 4:30PM
Business Wire
Broadens Livestock Digital Portfolio to
Improve Animal Well-being Through Connected Technology
Merck Animal Health, known as MSD Animal Health outside the
United States and Canada, a division of Merck & Co., Inc.,
Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of
its acquisition of Quantified Ag®, a leading data and analytics
company that monitors cattle body temperature and movement in order
to detect illness early. In April 2018, Merck Animal Health
invested in Quantified Ag® and partially funded their development
work in data analytics in livestock. Specific terms of the
agreement were not disclosed.
Today’s announcement further positions Merck Animal Health as a
global leader in animal health, broadening its portfolio in
connected technology to improve cattle health outcomes by
leveraging data and analytics for animal health and well-being.
Quantified Ag®, located in Lincoln, Nebraska, provides a pro-active
system for cattle producers and feedlot operators to track an
animal’s biometrics and behavioral data through a non-invasive
cattle ear tag equipped with sensors to monitor the health of the
individual animal or herd. The technology can detect animal
illness, thus reducing the potential for disease outbreak, allowing
for easy identification of sick animals, and providing easy-to-use
software reports on any mobile device, desktop, tablet or secure
website. Proprietary algorithms are able to identify animals
showing signs of illness or disease and provide real-time
alerts.
Quantified Ag® product portfolio will join the Allflex Livestock
Intelligence business unit within Merck Animal Health. Allflex
Livestock Intelligence is a complementary business that specializes
in identification and monitoring technology that delivers
real-time, actionable data and insights to help improve livestock
management.
“We are pleased to take this step forward with Quantified Ag® as
we continue to broaden our portfolio with complementary products
and technologies to advance animal well-being for our customers,”
said Rick DeLuca, president, Merck Animal Health. “Our goal is to
improve the detection of animal illness, and the responsible use of
treatments to maintain the health of livestock. We are at the
technological forefront of shaping the future of animal health
through our commitment to leveraging our scientific and technical
capabilities and expertise through comprehensive solutions to
manage the health and well-being of animals.”
New digitally based tools that enable rapid large-scale, data
capture coupled with powerful data management platforms for rapid
analysis and monitoring are transforming the farming and companion
animal industries. This more informed approach to animal health and
disease prevention is facilitating improved process management,
thereby enhancing yields, overall efficiency and sustainability
while complementing the portfolio of veterinary pharmaceuticals and
vaccines at Merck Animal Health.
Vishal Singh, co-founder and chief executive officer, Quantified
Ag®, said, “We believe that Merck Animal Health is the right
company, ideally positioned to keep developing our products in a
sustainable manner. We’ve enjoyed a collaborative partnership over
the past few years and are pleased with this next step.”
About Merck Animal Health For more than a century, Merck, a
leading global biopharmaceutical company, has been inventing for
life, bringing forward medicines and vaccines for many of the
world’s most challenging diseases. Merck Animal Health, a division
of Merck & Co., Inc., Kenilworth, N.J., USA, is the global
animal health business unit of Merck. Through its commitment to The
Science of Healthier Animals®, Merck Animal Health offers
veterinarians, farmers, pet owners and governments one of the
widest ranges of veterinary pharmaceuticals, vaccines and health
management solutions and services as well as an extensive suite of
digitally connected identification, traceability and monitoring
products. Merck Animal Health is dedicated to preserving and
improving the health, well-being and performance of animals and the
people who care for them. It invests extensively in dynamic and
comprehensive R&D resources and a modern, global supply chain.
Merck Animal Health is present in more than 50 countries, while its
products are available in some 150 markets. For more information,
visit www.merck-animal-health.com or connect with us on LinkedIn,
Facebook, and Twitter at @MerckAH.
Forward-Looking Statement of Merck & Co., Inc.,
Kenilworth, N.J., USA This news release of Merck & Co.,
Inc., Kenilworth, N.J., USA (the “company”) includes
“forward-looking statements” within the meaning of the safe harbor
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These statements are based upon the current beliefs and
expectations of the company’s management and are subject to
significant risks and uncertainties. If underlying assumptions
prove inaccurate or risks or uncertainties materialize, actual
results may differ materially from those set forth in the
forward-looking statements.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations;
the impact of the recent global outbreak of novel coronavirus
disease (COVID-19); the impact of pharmaceutical industry
regulation and health care legislation in the United States and
internationally; global trends toward health care cost containment;
technological advances, new products and patents attained by
competitors; challenges inherent in new product development,
including obtaining regulatory approval; the company’s ability to
accurately predict future market conditions; manufacturing
difficulties or delays; financial instability of international
economies and sovereign risk; dependence on the effectiveness of
the company’s patents and other protections for innovative
products; and the exposure to litigation, including patent
litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in the company’s 2019
Annual Report on Form 10-K and the company’s other filings with the
Securities and Exchange Commission (SEC) available at the SEC’s
Internet site (www.sec.gov).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200617005636/en/
Merck Media Contacts: Jeanette Lewis + 1 (973) 294-0318
Jeanette.Lewis@merck.com Pam Eisele +1 (267) 305-3558
Pamela.Eisele@merck.com Merck Investor Contact: Michael DeCarbo + 1
(908) 740-1807 Michael.DeCarbo@merck.com
Merck (NYSE:MRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Sep 2023 to Sep 2024